Pila Pharma
2.64 SEK +11.39%Be the first to follow this company
Pila Pharma operates in the pharmaceutical industry. The company conducts clinical trials in phase 2 with pharmaceuticals for type 2 diabetes. The main product is a tablet that is taken orally at an early stage of diabetes to restore the body's insulin production and thereby reduce the patient's blood sugar level. The business with associated research is conducted in Sweden.
Revenue
1.46M
EBIT %
-437.67 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
PILA
Daily low / high price
2.37 / 3.11
SEK
Market cap
62.81M SEK
Turnover
295.14K SEK
Volume
113K
Latest videos
Financial calendar
Interim report
2024-04-24
Interim report
2024-08-27
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Dorte X. Gram genom bolag | 21.8 % | 21.8 % |
Vimpu Intressenter AB | 16.7 % | 16.7 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
PILA PHARMA TO PRESENT IN ODENSE, DENMARK & ONLINE
CEO COMMENT ON NOMINATION TO BECOME NEXT CHAIRMAN
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools